157
Participants
Start Date
September 30, 2019
Primary Completion Date
February 22, 2024
Study Completion Date
April 23, 2024
Benralizumab
subcutaneous injection
Belfast City Hospital, Belfast
Birmingham Heartlands Hospital, Birmingham
Bradford Royal Infirmary, Bradford
Gartnavel General Hospital, Glasgow
Castle Hill Hospital, Hull
Glenfield Hospital, Leicester
Royal Liverpool University Hospital, Liverpool
Guy's and St Thomas's Hospital, London
Royal Brompton Hospital, London
Royal Free Hospital, London
Wythenshawe Hospital, Manchester
Freeman Hospital, Newcastle
Churchill Hospital, Oxford
Queen Alexandra Hospital, Portsmouth
Southampton General Hospital, Southampton
Collaborators (2)
University of Glasgow
OTHER
AstraZeneca
INDUSTRY
Queen's University, Belfast
OTHER
Bosch Healthcare Solutions GmbH
INDUSTRY
InHealthcare
UNKNOWN
University of Leicester
OTHER
University of Plymouth
OTHER
Vitalograph
UNKNOWN
NHS Greater Glasgow and Clyde
OTHER